163 related articles for article (PubMed ID: 36388460)
1. A ferroptosis-inducing biomimetic nanocomposite for the treatment of drug-resistant prostate cancer.
Chen J; Wang Y; Han L; Wang R; Gong C; Yang G; Li Z; Gao S; Yuan Y
Mater Today Bio; 2022 Dec; 17():100484. PubMed ID: 36388460
[TBL] [Abstract][Full Text] [Related]
2. Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis.
Nassar ZD; Mah CY; Dehairs J; Burvenich IJ; Irani S; Centenera MM; Helm M; Shrestha RK; Moldovan M; Don AS; Holst J; Scott AM; Horvath LG; Lynn DJ; Selth LA; Hoy AJ; Swinnen JV; Butler LM
Elife; 2020 Jul; 9():. PubMed ID: 32686647
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of phosphoglycerate dehydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cells.
Wang J; Zeng L; Wu N; Liang Y; Jin J; Fan M; Lai X; Chen ZS; Pan Y; Zeng F; Deng F
Drug Resist Updat; 2023 Sep; 70():100985. PubMed ID: 37423117
[TBL] [Abstract][Full Text] [Related]
4. Polyunsaturated Fatty Acids Drive Lipid Peroxidation during Ferroptosis.
Mortensen MS; Ruiz J; Watts JL
Cells; 2023 Mar; 12(5):. PubMed ID: 36899940
[TBL] [Abstract][Full Text] [Related]
5. Ether lipid deficiency disrupts lipid homeostasis leading to ferroptosis sensitivity.
Perez MA; Clostio AJ; Houston IR; Ruiz J; Magtanong L; Dixon SJ; Watts JL
PLoS Genet; 2022 Sep; 18(9):e1010436. PubMed ID: 36178986
[TBL] [Abstract][Full Text] [Related]
6. Dihydroxy-Metabolites of Dihomo-gamma-linolenic Acid Drive Ferroptosis-Mediated Neurodegeneration.
Sarparast M; Pourmand E; Hinman J; Vonarx D; Reason T; Zhang F; Paithankar S; Chen B; Borhan B; Watts JL; Alan J; Lee KSS
bioRxiv; 2023 Jan; ():. PubMed ID: 36711920
[TBL] [Abstract][Full Text] [Related]
7. Dihydroxy-Metabolites of Dihomo-γ-linolenic Acid Drive Ferroptosis-Mediated Neurodegeneration.
Sarparast M; Pourmand E; Hinman J; Vonarx D; Reason T; Zhang F; Paithankar S; Chen B; Borhan B; Watts JL; Alan J; Lee KSS
ACS Cent Sci; 2023 May; 9(5):870-882. PubMed ID: 37252355
[TBL] [Abstract][Full Text] [Related]
8. Dietary intake of concentrated gamma-linolenic acid (GLA)-enriched oil suppresses cutaneous level of dihomo-gamma-linolenic acid (DGLA): possible in vivo inhibition of microsomal elongation of GLA to DGLA.
Navarette R; Tang W; Ziboh VA
Prostaglandins Leukot Essent Fatty Acids; 1992 Jun; 46(2):139-44. PubMed ID: 1323857
[TBL] [Abstract][Full Text] [Related]
9. Targeting CPT1B as a potential therapeutic strategy in castration-resistant and enzalutamide-resistant prostate cancer.
Abudurexiti M; Zhu W; Wang Y; Wang J; Xu W; Huang Y; Zhu Y; Shi G; Zhang H; Zhu Y; Shen Y; Dai B; Wan F; Lin G; Ye D
Prostate; 2020 Sep; 80(12):950-961. PubMed ID: 32648618
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cholesterol biosynthesis overcomes enzalutamide resistance in castration-resistant prostate cancer (CRPC).
Kong Y; Cheng L; Mao F; Zhang Z; Zhang Y; Farah E; Bosler J; Bai Y; Ahmad N; Kuang S; Li L; Liu X
J Biol Chem; 2018 Sep; 293(37):14328-14341. PubMed ID: 30089652
[TBL] [Abstract][Full Text] [Related]
11. Biomimetic Activator of Sonodynamic Ferroptosis Amplifies Inherent Peroxidation for Improving the Treatment of Breast Cancer.
Zhou A; Fang T; Chen K; Xu Y; Chen Z; Ning X
Small; 2022 Mar; 18(12):e2106568. PubMed ID: 35092152
[TBL] [Abstract][Full Text] [Related]
12. Ferroptosis inducer erastin downregulates androgen receptor and its splice variants in castration‑resistant prostate cancer.
Yang Y; Liu T; Hu C; Xia H; Liu W; Chen J; Wu S; Jiang Y; Xu Y; Liu W; Zhao L
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649848
[TBL] [Abstract][Full Text] [Related]
13. Moving Towards Precision Urologic Oncology: Targeting Enzalutamide-resistant Prostate Cancer and Mutated Forms of the Androgen Receptor Using the Novel Inhibitor Darolutamide (ODM-201).
Borgmann H; Lallous N; Ozistanbullu D; Beraldi E; Paul N; Dalal K; Fazli L; Haferkamp A; Lejeune P; Cherkasov A; Gleave ME
Eur Urol; 2018 Jan; 73(1):4-8. PubMed ID: 28851578
[TBL] [Abstract][Full Text] [Related]
14. Dihomo-γ-linolenic acid inhibits xenograft tumor growth in mice bearing shRNA-transfected HCA-7 cells targeting delta-5-desaturase.
Xu Y; Yang X; Gao D; Yang L; Miskimins K; Qian SY
BMC Cancer; 2018 Dec; 18(1):1268. PubMed ID: 30567534
[TBL] [Abstract][Full Text] [Related]
15. Effect of dietary polyunsaturated fatty acids on castration-resistant Pten-null prostate cancer.
Wang S; Wu J; Suburu J; Gu Z; Cai J; Axanova LS; Cramer SD; Thomas MJ; Perry DL; Edwards IJ; Mucci LA; Sinnott JA; Loda MF; Sui G; Berquin IM; Chen YQ
Carcinogenesis; 2012 Feb; 33(2):404-12. PubMed ID: 22159221
[TBL] [Abstract][Full Text] [Related]
16. Free radical derivatives formed from cyclooxygenase-catalyzed dihomo-γ-linolenic acid peroxidation can attenuate colon cancer cell growth and enhance 5-fluorouracil's cytotoxicity.
Xu Y; Qi J; Yang X; Wu E; Qian SY
Redox Biol; 2014; 2():610-8. PubMed ID: 25114837
[TBL] [Abstract][Full Text] [Related]
17. Alterations of androgen receptor-regulated enhancer RNAs (eRNAs) contribute to enzalutamide resistance in castration-resistant prostate cancer.
Zhao J; Zhao Y; Wang L; Zhang J; Karnes RJ; Kohli M; Wang G; Huang H
Oncotarget; 2016 Jun; 7(25):38551-38565. PubMed ID: 27221037
[TBL] [Abstract][Full Text] [Related]
18. Iminodibenzyl redirected cyclooxygenase-2 catalyzed dihomo-γ-linolenic acid peroxidation pattern in lung cancer.
Pang L; Shah H; Qian S; Sathish V
Free Radic Biol Med; 2021 Aug; 172():167-180. PubMed ID: 34102280
[TBL] [Abstract][Full Text] [Related]
19. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of delta-5-desaturase promotes the anti-cancer activity of dihomo-γ-linolenic acid and enhances the efficacy of chemotherapy in colon cancer cells expressing COX-2.
Xu Y; Yang X; Zhao P; Yang Z; Yan C; Guo B; Qian SY
Free Radic Biol Med; 2016 Jul; 96():67-77. PubMed ID: 27101738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]